References

References1.Goodacre S, Irons R. ABC of clinical electrocardiography: atrial arrhythmias. BMJ 2002;324:594–597.GoodacreS]]IronsRABC of clinical electrocardiography: atrial arrhythmias.BMJ2002324594-5972.Kannel WB, Benjamin EJ. Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin 2009;27:13–24, vii.KannelWB]]BenjaminEJCurrent perceptions of the epidemiology of atrial fibrillation.Cardiol Clin20092713-24, vii3.Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—excutive summary. Rev Port Cardiol 2007;26:383–446.FusterV]]RydénLE]]CannomDS&etal;ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—excutive summary.Rev Port Cardiol200726383-4464.Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983–988.WolfPA]]AbbottRD]]KannelWBAtrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke199122983-9885.Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946–952.BenjaminEJ]]WolfPA]]D’AgostinoRB&etal;Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.Circulation199898946-9526.Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359–364.StewartS]]HartCL]]HoleDJ&etal;A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.Am J Med2002113359-3647.Le Heuzey JY, Paziaud O, Piot O, et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am Heart J 2004;147:121–126.Le HeuzeyJY]]PaziaudO]]PiotO&etal;Cost of care distribution in atrial fibrillation patients: the COCAF study.Am Heart J2004147121-1268.Aloul BA, Adabag AS, Can I, et al. Electrocardiographic markers of cardioversion success in patients with atrial fibrillation. South Med J 2009;102:885–889.AloulBA]]AdabagAS]]CanI&etal;Electrocardiographic markers of cardioversion success in patients with atrial fibrillation.South Med J2009102885-8899.Van Gelder IC, Crijns HJ, Tieleman RG, et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 1996;156:2585–2592.Van GelderIC]]CrijnsHJ]]TielemanRG&etal;Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation.Arch Intern Med19961562585-259210.Crijns HJ, Van Gelder IC, Tieleman RG, et al. Long-term outcome of electrical cardioversion in patients with chronic atrial flutter. Heart 1997;77:56–61.CrijnsHJ]]Van GelderIC]]TielemanRG&etal;Long-term outcome of electrical cardioversion in patients with chronic atrial flutter.Heart19977756-6111.Fetsch T, Bauer P, Engberding R, et al. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 2004;25:1385–1394.FetschT]]BauerP]]EngberdingR&etal;Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.Eur Heart J2004251385-139412.Feinstein AR. The unit fragility index: an additional appraisal of “statistical significance” for a contrast of two proportions. J Clin Epidemiol 1990;43:201–209.FeinsteinARThe unit fragility index: an additional appraisal of “statistical significance” for a contrast of two proportions.J Clin Epidemiol199043201-20913.Walter SD. Statistical significance and fragility criteria for assessing a difference of two proportions. J Clin Epidemiol 1991;44:1373–1378.WalterSDStatistical significance and fragility criteria for assessing a difference of two proportions.J Clin Epidemiol1991441373-1378